| ||
| Boehringer Ingelheim to Present New Data on PGx NSCLC Drug ... Boehringer Ingelheim will present at an upcoming oncology conference new pharmacogenomic data on its investigational non-small cell lung cancer drug afatinib. The company will present the data, gathered from an expanded patient cohort ... - http://www.genomeweb.com/newsletter/10910 |
| ||
| Classification of Non-Small Cell Lung Carcinoma in Trans-Thoracic ... Background: Emerging targeted lung cancer therapies require the accurate morphological sub-classification of non-small cell lung cancer (NSCLC), ... chestjournal.chestpubs.org/content/.../chest.11-0708.abstract |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment